Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 2 2

Status

Terminated 2Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 13Head & Neck 5Genitourinary 5Thoracic 4Sarcoma 4Gynecologic 2Dermatologic 2CNS 2Tumor-Agnostic 1Breast 1

Conditions

Nasopharyngeal Carcinoma 4Squamous Cell Carcinoma of Head and Neck 1Melanoma 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Heavy Ion Radiotherapy × Head & Neck × Clear all
NCT02795195 2025-08-07

Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma

Shanghai Proton and Heavy Ion Center

Phase 1/2 Completed
51 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05229614 2024-08-21

ICONIC

CNAO National Center of Oncological Hadrontherapy

Phase 2 Recruiting
27 enrolled
DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Melanoma

NCT04143984 2022-04-29

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

Shanghai Proton and Heavy Ion Center

Phase 2 Unknown
146 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT02569788 2020-02-17

Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Shanghai Proton and Heavy Ion Center

Phase 1/2 Terminated
9 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT02801487 2020-02-17

Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Shanghai Proton and Heavy Ion Center

Phase 1/2 Terminated
6 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡